ArticleEuropean journal of nuclear medicine and molecular imaging2025

CD13 as a potential theranostic target for prostate-specific membrane antigen-negative prostate cancer and first-in-human study of [

Wei Tang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.